Drugmakers unite to ease rules on off-label promotion

Ten major drugmakers, including Pfizer and AstraZeneca, have established an alliance to push for more relaxed government rules on the promotion of drugs for off-label uses. The FDA has issued draft guidelines that it says clarify the rules for disseminating information about unapproved uses.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA